메뉴 건너뛰기




Volumn 3, Issue 2, 2016, Pages 117-127

Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): A double-blind, randomised, placebo-controlled trial

(18)  McAllister Williams, R Hamish a,c   Anderson, Ian M d   Finkelmeyer, Andreas a,c   Gallagher, Peter a   Grunze, Heinz C R a,c,e   Haddad, Peter M d,f   Hughes, Tom g   Lloyd, Adrian J a,c   Mamasoula, Chrysovalanto b   McColl, Elaine b   Pearce, Simon a   Siddiqi, Najma h,i   Sinha, Baxi N P j   Steen, Nick b   Wainwright, June a   Winter, Fiona H a   Ferrier, I Nicol a,c   Watson, Stuart a,c  


Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; METYRAPONE; PLACEBO;

EID: 84957358673     PISSN: 22150366     EISSN: 22150374     Source Type: Journal    
DOI: 10.1016/S2215-0366(15)00436-8     Document Type: Article
Times cited : (37)

References (38)
  • 2
    • 45349107889 scopus 로고    scopus 로고
    • Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines
    • Anderson IM, Ferrier IN, Baldwin RC, et al. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol 2008, 22:343-396.
    • (2008) J Psychopharmacol , vol.22 , pp. 343-396
    • Anderson, I.M.1    Ferrier, I.N.2    Baldwin, R.C.3
  • 3
    • 30044433660 scopus 로고    scopus 로고
    • Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice
    • Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006, 163:28-40.
    • (2006) Am J Psychiatry , vol.163 , pp. 28-40
    • Trivedi, M.H.1    Rush, A.J.2    Wisniewski, S.R.3
  • 4
    • 33751338530 scopus 로고    scopus 로고
    • Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report
    • Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006, 163:1905-1917.
    • (2006) Am J Psychiatry , vol.163 , pp. 1905-1917
    • Rush, A.J.1    Trivedi, M.H.2    Wisniewski, S.R.3
  • 5
    • 3042694388 scopus 로고    scopus 로고
    • HPA axis activation in major depression and response to fluoxetine: a pilot study
    • Young EA, Altemus M, Lopez JF, et al. HPA axis activation in major depression and response to fluoxetine: a pilot study. Psychoneuroendocrinology 2004, 29:1198-1204.
    • (2004) Psychoneuroendocrinology , vol.29 , pp. 1198-1204
    • Young, E.A.1    Altemus, M.2    Lopez, J.F.3
  • 6
    • 84883657037 scopus 로고    scopus 로고
    • Salivary cortisol levels and the 2-year course of depressive and anxiety disorders
    • Vreeburg SA, Hoogendijk WJ, DeRijk RH, et al. Salivary cortisol levels and the 2-year course of depressive and anxiety disorders. Psychoneuroendocrinology 2013, 38:1494-1502.
    • (2013) Psychoneuroendocrinology , vol.38 , pp. 1494-1502
    • Vreeburg, S.A.1    Hoogendijk, W.J.2    DeRijk, R.H.3
  • 8
    • 10044222004 scopus 로고    scopus 로고
    • Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial
    • Jahn H, Schick M, Kiefer F, Kellner M, Yassouridis A, Wiedemann K Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial. Arch Gen Psychiatry 2004, 61:1235-1244.
    • (2004) Arch Gen Psychiatry , vol.61 , pp. 1235-1244
    • Jahn, H.1    Schick, M.2    Kiefer, F.3    Kellner, M.4    Yassouridis, A.5    Wiedemann, K.6
  • 9
    • 84902819159 scopus 로고    scopus 로고
    • Hospital admission and community treatment of mental disorders in England from 1998 to 2012
    • Green BH, Griffiths EC Hospital admission and community treatment of mental disorders in England from 1998 to 2012. Gen Hosp Psychiatry 2014, 36:442-448.
    • (2014) Gen Hosp Psychiatry , vol.36 , pp. 442-448
    • Green, B.H.1    Griffiths, E.C.2
  • 10
    • 12344296282 scopus 로고    scopus 로고
    • A single dose of metyrapone caused long-term dysregulation of the hypothalamic-pituitary-adrenal axis in the rat
    • Rotllant D, Armario A A single dose of metyrapone caused long-term dysregulation of the hypothalamic-pituitary-adrenal axis in the rat. Neuroscience 2005, 130:427-434.
    • (2005) Neuroscience , vol.130 , pp. 427-434
    • Rotllant, D.1    Armario, A.2
  • 11
    • 49249098961 scopus 로고    scopus 로고
    • Persistent effects of mifepristone (RU-486) on cortisol levels in bipolar disorder and schizophrenia
    • Gallagher P, Watson S, Elizabeth DC, Young AH, Ferrier IN Persistent effects of mifepristone (RU-486) on cortisol levels in bipolar disorder and schizophrenia. J Psychiatr Res 2008, 42:1037-1041.
    • (2008) J Psychiatr Res , vol.42 , pp. 1037-1041
    • Gallagher, P.1    Watson, S.2    Elizabeth, D.C.3    Young, A.H.4    Ferrier, I.N.5
  • 12
    • 84880868083 scopus 로고    scopus 로고
    • Study protocol for the randomised controlled trial: Antiglucocorticoid augmentation of anti-Depressants in Depression (The ADD Study)
    • McAllister-Williams RH, Smith E, et al. Study protocol for the randomised controlled trial: Antiglucocorticoid augmentation of anti-Depressants in Depression (The ADD Study). BMC Psychiatry 2013, 13:205.
    • (2013) BMC Psychiatry , vol.13 , pp. 205
    • McAllister-Williams, R.H.1    Smith, E.2
  • 14
    • 0026769858 scopus 로고
    • The structured clinical interview for DSM-III-R (SCID). I: history, rationale, and description
    • Spitzer
    • Spitzer RL, Williams JB, Gibbon M, First MB The structured clinical interview for DSM-III-R (SCID). I: history, rationale, and description. Arch Gen Psychiatry 1992, 49:624-629.
    • (1992) Arch Gen Psychiatry , vol.49 , pp. 624-629
    • Spitzer, R.L.1    Williams, J.B.2    Gibbon, M.3    First, M.B.4
  • 15
    • 0014186152 scopus 로고
    • Development of a rating scale for primary depressive illness
    • Hamilton M Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967, 6:278-296.
    • (1967) Br J Soc Clin Psychol , vol.6 , pp. 278-296
    • Hamilton, M.1
  • 16
    • 42149190590 scopus 로고    scopus 로고
    • The GRID-HAMD: standardization of the Hamilton Depression Rating Scale
    • Williams JB, Kobak KA, Bech P, et al. The GRID-HAMD: standardization of the Hamilton Depression Rating Scale. Int Clin Psychopharmacol 2008, 23:120-129.
    • (2008) Int Clin Psychopharmacol , vol.23 , pp. 120-129
    • Williams, J.B.1    Kobak, K.A.2    Bech, P.3
  • 17
    • 0038147546 scopus 로고    scopus 로고
    • Diagnosis and definition of treatment-resistant depression
    • Fava M Diagnosis and definition of treatment-resistant depression. Biol Psychiatry 2003, 53:649-659.
    • (2003) Biol Psychiatry , vol.53 , pp. 649-659
    • Fava, M.1
  • 18
    • 0342656121 scopus 로고    scopus 로고
    • Genetic factors, perceived chronic stress, and the free cortisol response to awakening
    • Wust S, Federenko I, Hellhammer DH, Kirschbaum C Genetic factors, perceived chronic stress, and the free cortisol response to awakening. Psychoneuroendocrinology 2000, 25:707-720.
    • (2000) Psychoneuroendocrinology , vol.25 , pp. 707-720
    • Wust, S.1    Federenko, I.2    Hellhammer, D.H.3    Kirschbaum, C.4
  • 20
    • 0041698274 scopus 로고    scopus 로고
    • Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change
    • Pruessner JC, Kirschbaum C, Meinlschmid G, Hellhammer DH Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 2003, 28:916-931.
    • (2003) Psychoneuroendocrinology , vol.28 , pp. 916-931
    • Pruessner, J.C.1    Kirschbaum, C.2    Meinlschmid, G.3    Hellhammer, D.H.4
  • 21
    • 33947634607 scopus 로고    scopus 로고
    • Effects of metyrapone on hypothalamic-pituitary-adrenal axis and sleep in women with post-traumatic stress disorder
    • Otte C, Lenoci M, Metzler T, Yehuda R, Marmar CR, Neylan TC Effects of metyrapone on hypothalamic-pituitary-adrenal axis and sleep in women with post-traumatic stress disorder. Biol Psychiatry 2007, 61:952-956.
    • (2007) Biol Psychiatry , vol.61 , pp. 952-956
    • Otte, C.1    Lenoci, M.2    Metzler, T.3    Yehuda, R.4    Marmar, C.R.5    Neylan, T.C.6
  • 22
    • 0018425438 scopus 로고
    • A new depression scale designed to be sensitive to change
    • Montgomery SA, Asberg M A new depression scale designed to be sensitive to change. Bri J Psychiatry 1979, 134:382-389.
    • (1979) Bri J Psychiatry , vol.134 , pp. 382-389
    • Montgomery, S.A.1    Asberg, M.2
  • 23
    • 0019898881 scopus 로고
    • The Clinical Anxiety Scale: an instrument derived from the Hamilton Anxiety Scale
    • Snaith RP, Baugh SJ, Clayden AD, Husain A, Sipple MA The Clinical Anxiety Scale: an instrument derived from the Hamilton Anxiety Scale. Br J Psychiatry 1982, 141:518-523.
    • (1982) Br J Psychiatry , vol.141 , pp. 518-523
    • Snaith, R.P.1    Baugh, S.J.2    Clayden, A.D.3    Husain, A.4    Sipple, M.A.5
  • 26
    • 0018175277 scopus 로고
    • A rating scale for mania: reliability, validity and sensitivity
    • Young RC, Biggs JT, Ziegler VE, Meyer DA A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978, 133:429-435.
    • (1978) Br J Psychiatry , vol.133 , pp. 429-435
    • Young, R.C.1    Biggs, J.T.2    Ziegler, V.E.3    Meyer, D.A.4
  • 27
    • 0025688231 scopus 로고
    • EuroQol-a new facility for the measurement of health-related quality of life
    • EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 1990, 16:199-208. EuroQol Group.
    • (1990) Health Policy , vol.16 , pp. 199-208
  • 28
    • 0036240464 scopus 로고    scopus 로고
    • Antidepressant side effects in depression patients treated in a naturalistic setting: a study of bupropion, moclobemide, paroxetine, sertraline, and venlafaxine
    • Vanderkooy JD, Kennedy SH, Bagby RM Antidepressant side effects in depression patients treated in a naturalistic setting: a study of bupropion, moclobemide, paroxetine, sertraline, and venlafaxine. Can J Psychiatry 2002, 47:174-180.
    • (2002) Can J Psychiatry , vol.47 , pp. 174-180
    • Vanderkooy, J.D.1    Kennedy, S.H.2    Bagby, R.M.3
  • 29
    • 0032421570 scopus 로고    scopus 로고
    • The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10
    • Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998, 59(suppl):22-33.
    • (1998) J Clin Psychiatry , vol.59 , pp. 22-33
    • Sheehan, D.V.1    Lecrubier, Y.2    Sheehan, K.H.3
  • 30
    • 0030131087 scopus 로고    scopus 로고
    • The relationship between the effects of metyrapone treatment on depressed mood and urinary steroid profiles
    • Raven PW, O'Dwyer AM, Taylor NF, Checkley SA The relationship between the effects of metyrapone treatment on depressed mood and urinary steroid profiles. Psychoneuroendocrinology 1996, 21:277-286.
    • (1996) Psychoneuroendocrinology , vol.21 , pp. 277-286
    • Raven, P.W.1    O'Dwyer, A.M.2    Taylor, N.F.3    Checkley, S.A.4
  • 31
    • 84868215259 scopus 로고    scopus 로고
    • A randomized trial to examine the effect of mifepristone on neuropsychological performance and mood in patients with bipolar depression
    • Watson S, Gallagher P, Porter RJ, et al. A randomized trial to examine the effect of mifepristone on neuropsychological performance and mood in patients with bipolar depression. Biol Psychiatry 2012, 72:943-949.
    • (2012) Biol Psychiatry , vol.72 , pp. 943-949
    • Watson, S.1    Gallagher, P.2    Porter, R.J.3
  • 32
    • 35848945707 scopus 로고    scopus 로고
    • Glucocorticoid receptor antagonists hasten and augment neurochemical responses to a selective serotonin reuptake inhibitor antidepressant
    • Johnson DA, Grant EJ, Ingram CD, Gartside SE Glucocorticoid receptor antagonists hasten and augment neurochemical responses to a selective serotonin reuptake inhibitor antidepressant. Biol Psychiatry 2007, 62:1228-1235.
    • (2007) Biol Psychiatry , vol.62 , pp. 1228-1235
    • Johnson, D.A.1    Grant, E.J.2    Ingram, C.D.3    Gartside, S.E.4
  • 33
    • 77958150431 scopus 로고    scopus 로고
    • Discrepancy between subjective and objective severity in treatment-resistant depression: prediction of treatment outcome
    • Rane LJ, Fekadu A, Wooderson S, Poon L, Markopoulou K, Cleare AJ Discrepancy between subjective and objective severity in treatment-resistant depression: prediction of treatment outcome. J Psychiatr Res 2010, 44:1082-1087.
    • (2010) J Psychiatr Res , vol.44 , pp. 1082-1087
    • Rane, L.J.1    Fekadu, A.2    Wooderson, S.3    Poon, L.4    Markopoulou, K.5    Cleare, A.J.6
  • 34
    • 14644401055 scopus 로고    scopus 로고
    • Is there a delay in the antidepressant effect? A meta-analysis
    • Posternak MA, Zimmerman M Is there a delay in the antidepressant effect? A meta-analysis. J Clin Psychiatry 2005, 66:148-158.
    • (2005) J Clin Psychiatry , vol.66 , pp. 148-158
    • Posternak, M.A.1    Zimmerman, M.2
  • 36
    • 79951514630 scopus 로고    scopus 로고
    • Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research
    • Stetler C, Miller GE Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom Med 2011, 73:114-126.
    • (2011) Psychosom Med , vol.73 , pp. 114-126
    • Stetler, C.1    Miller, G.E.2
  • 37
    • 84901024568 scopus 로고    scopus 로고
    • Gene-environment interactions and intermediate phenotypes: early trauma and depression
    • Hornung OP, Heim CM Gene-environment interactions and intermediate phenotypes: early trauma and depression. Front Endocrinol (Lausanne) 2014, 5:14.
    • (2014) Front Endocrinol (Lausanne) , vol.5 , pp. 14
    • Hornung, O.P.1    Heim, C.M.2
  • 38
    • 84874508475 scopus 로고    scopus 로고
    • Looking beyond the DNA sequence: the relevance of DNA methylation processes for the stress-diathesis model of depression
    • Booij L, Wang D, Levesque ML, Tremblay RE, Szyf M Looking beyond the DNA sequence: the relevance of DNA methylation processes for the stress-diathesis model of depression. Philos Trans R Soc Lond B Biol Sci 2013, 368:20120251.
    • (2013) Philos Trans R Soc Lond B Biol Sci , vol.368 , pp. 20120251
    • Booij, L.1    Wang, D.2    Levesque, M.L.3    Tremblay, R.E.4    Szyf, M.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.